Clinical Trial Update: Chart Review of Repatha® in Subjects With Hyperlipidaemia

View source ↗

Summary

This is a completed chart-review study evaluating the use of Repatha (evolocumab) in subjects with hyperlipidemia and/or hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Repatha (Evolocumab)

Snippet

Sponsor: Amgen | Conditions: Hypercholesterolaemia | Status: COMPLETED